Komori T, Arai N, Oda M, Nakayama H, Mori H, Yagishita S, Takahashi T, Amano N, Murayama S, Murakami S, Shibata N, Kobayashi M, Sasaki S, Iwata M
Department of Clinical Neuropathology, Tokyo Metropolitan Institute for Neuroscience, Fuchu City, Japan.
Acta Neuropathol. 1998 Oct;96(4):401-8. doi: 10.1007/s004010050911.
Corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) are characterized by their unique clinical features and neuronal pathology. Although astrocytic plaques and tufts of abnormal fibers have been suggested to be specific histopathologic markers, recent studies have revealed significant clinicopathologic overlap between CBD and PSP. Based on the distinctive camera lucida profile of astrocytic inclusions on Gallyas-Braak silver staining, we found that astrocytic plaques and tufts of abnormal fibers did not coexist in the same patient among 30 cases of clinically diagnosed CBD, PSP and atypical Parkinson's disease. Using Tau immunohistochemistry it was difficult to verify the absence of tufts of abnormal fibers. A morphometric analysis revealed that the two groups classified by the presence or absence of astrocytic plaques and tufts of abnormal fibers exhibited significant differences in the density of ballooned neurons and neurofibrillary tangles and degeneration of the subcortical nuclei. Assessment using the NINDS neuropathologic criteria revealed that the cases with astrocytic plaques and tufts of abnormal fibers closely correspond to CBD and typical PSP, respectively. In addition, the cases lacking either of these two astrocytic inclusions had atypical PSP according to the NINDS criteria, and were associated with novel tau-positive astrocytes (spiny astrocytes). We thus conclude that astrocytic plaques and tufts of abnormal fibers are highly characteristic structures for CBD and typical PSP, respectively. We emphasize the importance of strict differentiation between different astrocytic inclusions not only for diagnosis, but also for further studies for elucidation of their role in the disease mechanisms of CBD and PSP.
皮质基底节变性(CBD)和进行性核上性麻痹(PSP)具有独特的临床特征和神经元病理学表现。尽管有人提出星形胶质细胞斑块和异常纤维束是特异性的组织病理学标志物,但最近的研究表明CBD和PSP之间存在显著的临床病理重叠。基于Gallyas-Braak银染色上星形胶质细胞包涵体独特的明视野轮廓,我们发现在30例临床诊断为CBD、PSP和非典型帕金森病的患者中,星形胶质细胞斑块和异常纤维束不会在同一患者中共存。使用Tau免疫组织化学很难证实异常纤维束不存在。形态计量分析显示,根据星形胶质细胞斑块和异常纤维束的有无分类的两组在气球样神经元密度、神经原纤维缠结以及皮质下核团变性方面存在显著差异。使用美国国立神经疾病与中风研究所(NINDS)神经病理学标准进行评估发现,有星形胶质细胞斑块和异常纤维束的病例分别与CBD和典型PSP密切对应。此外,根据NINDS标准,缺乏这两种星形胶质细胞包涵体之一 的病例具有非典型PSP,并且与新型tau阳性星形胶质细胞(棘状星形胶质细胞)有关。因此,我们得出结论,星形胶质细胞斑块和异常纤维束分别是CBD和典型PSP的高度特征性结构。我们强调严格区分不同的星形胶质细胞包涵体不仅对诊断很重要,而且对进一步研究阐明它们在CBD和PSP疾病机制中的作用也很重要。